Healthcare Services

Biosimilar Testing Services Market Future Outlook Showing Expansion Toward $3.37 Billion by 2030

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Biosimilar Testing Services Market Over The 2026–2030 Period?

The biosimilar testing services market has experienced significant expansion recently. This market is projected to expand from $1.84 billion in 2025 to $2.08 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.0%. Historically, this growth can be ascribed to factors such as the broadening of biosimilar development pipelines, the increase in regulatory clearances for biosimilars, the advancement of biologics manufacturing, a greater dependence on CRO testing services, and enhancements in analytical testing technologies.

The biosimilar testing services market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $3.37 billion, demonstrating a compound annual growth rate (CAGR) of 12.8%. This projected increase throughout the forecast period stems from the increasing need for economical biologic options, the expansion of worldwide biosimilar markets, the growing intricate nature of biologic molecules, a heightened emphasis on comparability evaluations, and rising investments in biosimilar research and development. Key developments anticipated during this period include a greater call for thorough analytical characterization, the increasing adoption of sophisticated bioanalytical assays, an intensified focus on testing services that comply with regulations, the broadening of outsourced support for biosimilar development, and a stronger emphasis on method validation and consistency.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27225&type=smp

What Drivers Are Expected To Influence The Biosimilar Testing Services Market During The Forecast Period?

The increasing incidence of autoimmune conditions is anticipated to drive expansion within the biosimilar testing services market moving ahead. These conditions occur when the body’s immune system erroneously targets its own healthy cells and tissues, resulting in inflammation and harm to those tissues. This rising prevalence stems from a greater demand for potent biologic therapies capable of managing chronic indicators, decreasing symptom exacerbations, and enhancing patient results over time. Biosimilar testing services facilitate the management of autoimmune diseases by verifying that biosimilars are safe, effective, and similar to their reference biologics, thereby contributing to the provision of affordable and readily available treatment alternatives. For example, data from February 2024 by Arthritis Australia, an Australian non-profit group, projects that 562,378 Australians will be affected by RA in 2025, constituting 14% of all arthritis cases during that period. By 2040, this figure is forecast to increase by 33% to 748,721 people. This signifies an additional 186,343 Australians living with RA when compared to 2025. Consequently, the expanding occurrence of autoimmune diseases is propelling the expansion of the biosimilar testing services market.

How Is The Biosimilar Testing Services Market Segmented Across Key Categories?

The biosimilar testing services market covered in this report is segmented –

1) By Service Type: Analytical Testing, Bioanalytical Testing, Stability Testing, Method Development And Validation, Other Service Types

2) By Technology: Cell-Based Assays, Chromatography Techniques, Mass Spectrometry, Bioassays

3) By Molecule Type: Monoclonal Antibodies, Recombinant Hormones, Insulin, Interferons, Enzymes, Other Molecule Types

4) By Application: Oncology, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications

5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Government Agencies

Subsegments:

1) By Analytical Testing: Protein Characterization, Impurity Profiling, Potency Testing, Glycosylation Analysis, Structural Analysis

2) By Bioanalytical Testing: Pharmacokinetics Analysis, Immunogenicity Testing, Biomarker Analysis, Drug Concentration Measurement, Toxicokinetics Testing

3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Testing, Photostability Testing, Temperature Cycling Studies

4) By Method Development And Validation: Analytical Method Development, Bioanalytical Method Development, Method Validation, Process Validation, Assay Development

5) By Other Service Types: Immunogenicity Assessment, Formulation Development, Microbial Testing, Release Testing, Regulatory Consulting

How Are Trends Impacting The Biosimilar Testing Services Market?

Leading firms within the biosimilar testing services market are prioritizing facility expansion to integrate novel technologies and capabilities, thereby boosting their productivity and competitive edge. This expansion involves either enlarging or enhancing current physical spaces or infrastructure to meet growing operational demands or to prepare for future development. As an illustration, Tanvex BioPharma USA Inc., a biotechnology company based in the US, introduced Tanvex CDMO in October 2023. This advanced contract development and manufacturing organization, situated in San Diego, provides comprehensive biologics development and manufacturing services, encompassing areas such as cell line development, process optimization, analytical testing, and regulatory assistance. The objective of this new facility is to expedite the progression of biopharmaceutical products from their initial concept phase to commercial production, utilizing leading-edge technologies and expert teams to supply groundbreaking and transformative biologics to patients globally.

Who Are The Dominant Players Shaping The Biosimilar Testing Services Market Landscape?

Major companies operating in the biosimilar testing services market are Thermo Fisher Scientific Inc., IQVIA Laboratories, Laboratory Corporation of America Holdings, Eurofins Scientific SE, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Intertek Group plc, Samsung Biologics Co. Ltd., Almac Group Limited, Syngene International Limited, Shanghai Medicilon Inc., Kymos Group S.L., Pacific BioLabs Inc., Profacgen Inc., ExcellGene SA, BioPharmaSpec Ltd., Charles River Laboratories International Inc., Covance Inc., PPD Inc., ICON plc, Parexel International Corporation, Frontage Laboratories Inc.

Read the full biosimilar testing services market report here:

https://www.thebusinessresearchcompany.com/report/biosimilar-testing-services-global-market-report

Which Region Is Forecast To Lead The Biosimilar Testing Services Market In Terms Of Market Size?

North America was the largest region in the biosimilar testing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosimilar testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biosimilar Testing Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27225&type=smp

Browse Through More Reports Similar to the Global Biosimilar Testing Services Market 2026, By The Business Research Company

Insulation Products Global Market Report

https://www.thebusinessresearchcompany.com/report/insulation-products-global-market-report

Aircraft Insulation Global Market Report

https://www.thebusinessresearchcompany.com/report/aircraft-insulation-global-market-report

Technical Insulation Global Market Report

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795